High blood pressure is common in acute stroke and associated with a worse functional outcome. Many patients who present with acute stroke are taking prescribed antihypertensive therapy before their stroke.
Aims
ENOS tested whether lowering blood pressure and continuing pre-stroke antihypertensive therapy are each safe and effective.
Methods
This study is an international multi-centre prospective randomized single-blind blinded-endpoint parallel-group partial-factorial controlled trial of transdermal glyceryl trinitrate (a nitric oxide donor, given for seven-days) vs. no glyceryl trinitrate, and of continuing vs. stopping (temporarily for seven-days) pre-stroke antihypertensive drugs if relevant, in patients with acute ischaemic stroke or intracerebral haemorrhage and high systolic blood pressure (140–220 mmHg).
Results
Recruitment ran from July 2001 to October 2013. Four thousand eleven patients [2097 (52·3%) in the continue/stop arm] were recruited from 173 sites across 23 countries in 5 continents (Asia 14%, Continental Europe 16%, UK 64%). Baseline characteristics include: mean age 70 (standard deviation 12) years; male 57%; mean time from stroke to recruitment 26 (13) h; mean severity (Scandinavian Stroke Scale) 34 (13) of 58; mean blood pressure 167 (19)/90 (13) mmHg; ischaemic stroke 83%; and intracerebral haemorrhage 16%. The main trial results will be presented in May 2014. The results will also be presented in updated Cochrane systematic reviews and included in individual patient data meta-analyses of all relevant randomized controlled trials.
Conclusion
ENOS is a large completed international trial of blood pressure management in acute stroke and includes patients representative of many stroke services worldwide.
Leonardi-BeeJBathPMWPhillipsSJSandercockPAG, for the IST Collaborative Group. Blood pressure and clinical outcomes in the International Stroke Trial. Stroke2002; 33: 1315–20.
2.
WillmotMLeonardi-BeeJBathPM. High blood pressure in acute stroke and subsequent outcome: A systematic review. Hypertension2004; 43: 18–24.
3.
SpriggNGrayLJBathPM. Relationship between outcome and baseline blood pressure and other haemodynamic measures in acute ischaemic stroke: Data from the TAIST trial. J Hypertens2006; 24: 1413–7.
4.
GeeganageCTracyMEnglandT. Relationship between baseline blood pressure parameters (including mean pressure, pulse pressure, and variability) and early outcome after stroke: Data from the tinzaparin in acute ischaemic stroke trial (TAIST). Stroke2011; 42: 491–3.
5.
HackeWRinglebPABousserMG. Guidelines for management of ischaemic stroke and transient ischaemic attack 2008 – The European Stroke Organisation (ESO) Executive Committee and the ESO Writing Committee. Cerebrovasc Dis2008; 25: 457–507.
6.
AndersonCSHeeleyEHuangY. Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage. N Engl J Med2013; 368: 2355–65.
7.
WillmotMRBathPMW. The potential of nitric oxide therapeutics in stroke. Expert Opin Investig Drugs2003; 12: 455–70.
8.
WillmotMMurphySLeonardi-BeeJBathP. Systematic review of nitric oxide donors and L-arginine in experimental stroke: Effects on infarct size and cerebral blood flow. Cerebrovasc Dis2003; 16: S366, abstract.1.
9.
ButterworthRJCluckieAJacksonSHDBuxton-ThomasMBathPMW. Pathophysiological assessment of nitric oxide (given as sodium nitroprusside) in acute ischaemic stroke. Cerebrovasc Dis1998; 8: 158–65.
10.
BathPMWPathansaliRIddendenRBathFJ. The effect of transdermal glyceryl trinitrate, a nitric oxide donor, on blood pressure and platelet function in acute stroke. Cerebrovasc Dis2001; 11: 265–72.
11.
RashidPWeaverCLeonardi-BeeJAFletcherSBathFJBathPMW. The effects of transdermal glyceryl trinitrate, a nitric oxide donor on blood pressure, cerebral and cardiac haemodynamics and plasma nitric oxide levels in acute stroke. J Stroke Cerebrovasc Dis2003; 13: 143–51.
12.
WillmotMGhadamiAWhysallBClarkeWWardlawJBathPM. Transdermal glyceryl trinitrate lowers blood pressure and maintains cerebral blood flow in recent stroke. Hypertension2006; 47: 1209–15.
13.
AnkolekarSFullerMCrossI. Feasibility of an ambulance-based stroke trial, and safety of glyceryl trinitrate in ultra-acute stroke: The rapid intervention with glyceryl trinitrate in hypertensive stroke trial (RIGHT, ISRCTN66434824). Stroke2013; 44: 3120–8.
GrayLJSpriggNRashidPAWillmotMBathPMW. Effect of nitric oxide donors on blood pressure and pulse pressure in acute and subacute stroke. J Stroke Cerebrovasc Dis2006; 15: 245–9.
18.
GeeganageCMBathAJBathPM. The effect of transdermal glyceryl trinitrate on 24 h ambulatory blood pressure in acute/subacute stroke. Int J Stroke2011; 6: 290–4.
19.
LeesKRDykerAG. Blood pressure control after acute stroke. J Hypertens1996; 14(Suppl. 6): S35–8.
20.
COSSACS Trial Group. COSSACS (Continue or Stop post-Stroke Antihypertensives Collaborative Study): Rationale and design. J Hypertens2005; 23: 455–8.
21.
RobinsonTGPotterJFFordGA. Effects of antihypertensive treatment after acute stroke in the Continue or Stop Post-Stroke Antihypertensives Collaborative Study (COSSACS): A prospective, randomised, open, blinded-endpoint trial. Lancet Neurol2010; 9: 767–75.
22.
The ENOS Trial Investigators. Glyceryl trinitrate vs. control, and continuing vs. stopping temporarily prior antihypertensive therapy, in acute stroke: Rationale and design of the Efficacy of Nitric Oxide in Stroke (ENOS) trial (ISRCTN99414122). Int J Stroke2006; 1: 245–9.
23.
GrayLJAliMLydenPDBathPMW. VISTA Collaborators. Interconversion of the National Institutes of Health Stroke Scale and Scandinavian Stroke Scale in acute stroke. J Stroke Cerebrovasc Dis2009; 18: 466–8.
24.
WeirCJLeesKR. Comparison of stratification and adaptive methods for treatment allocation in an acute stroke clinical trial. Stat Med2003; 22: 705–26.
25.
BathPMHoultonAWoodhouseLSpriggNWardlawJPocockS; On behalf of the ENOS Trialists. Statistical analysis plan for the ‘Efficacy of Nitric Oxide in Stroke’ (ENOS) trial. Int J Stroke2013; 9: 372–4.
26.
De SilvaDAOmarEManzanoJJ. Comparison of small volume infarcts of lacunar and non-lacunar etiologies. Int J Stroke2013; 8: E24–5.
27.
The Optimising Analysis of Stroke Trials (OAST) Collaboration. Can we improve the statistical analysis of stroke trials? Statistical re-analysis of functional outcomes in stroke trials. Stroke2007; 38: 1911–5.
28.
BathPMLeesKRSchellingerPD. Statistical analysis of the primary outcome in acute stroke trials. Stroke2012; 43: 1171–8.
29.
The Optimising Analysis of Stroke Trials (OAST) Collaboration. Should stroke trials adjust functional outcome for baseline prognostic factors?Stroke2009; 40: 888–94.
30.
SaverJL. Novel-end point analytic techniques and interpreting shifts across the entire range of outcome scales in acute stroke trials. Stroke2007; 38: 3055–62.
31.
SavitzSILewRBluhmkiEHackeWFisherM. Shift analysis versus dichotomization of the Modified Rankin scale outcome scores in the NINDS and ECASS-II trials. Stroke2007; 38: 3205–12.
32.
LeesKRZivinJAAshwoodT. NXY-059 for acute ischemic stroke. NEJM2006; 354: 588–99.
33.
KobayashiAGrabskaKCzlonkowskaAGrayLJBathPMW. Efficacy of Nitric Oxide in Stroke – ENOS – a randomized trial – characteristics of patients recruited in Poland. Neurol Neurochir Pol2008; 42: 99–104.
34.
IldikoSSSJurcauASimionA. The efficacy of nitric oxide in stroke (ENOS) Trial – where do we stand in Romania?Rom J Neurol2012; XI: 68–74.
35.
GrayLJAliMLydenPDBathPM. Interconversion of the National Institutes of Health Stroke Scale and Scandinavian Stroke Scale in acute stroke. J Stroke Cerebrovasc Dis2009; 18: 466–8.
36.
SandsetECBathPMBoysenG. The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): A randomised, placebo-controlled, double-blind trial. Lancet2011; 377: 741–50.
37.
Intravenous Magnesium Efficacy in Stroke (IMAGES) Study Investigators. Magnesium for acute stroke (Intravenous Magnesium Efficacy in Stroke trial): Randomised controlled trial. Lancet2004; 363: 439–45.
38.
SanossianNStarkmanSLiebeskindDS. Simultaneous ring voice-over-Internet phone system enables rapid physician elicitation of explicit informed consent in prehospital stroke treatment trials. Cerebrovasc Dis2009; 28: 539–44.
39.
HeJZhangYXuT. Effects of immediate blood pressure reduction on death and major disability in patients with acute ischemic stroke: The CATIS randomized clinical trial. JAMA2014; 311: 479–89.
